You are here
CHEMOSEN3D INC
UEI: LH32V6UMM1K5
# of Employees: 3
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Numeric Expansion of CD-19 Specific T cells in Magnetic 3D Culture
Amount: $175,849.00Project Summary Adoptive immunotherapy trials using genetically modified natural killerNKand T cells with redirected specificity against B cell malignancies have demonstrated therapeutic efficacyTwo e ...
STTRPhase I2018Department of Health and Human Services National Institutes of Health -
Development of high-throughput cardiotoxicity and hepatotoxicity assays with magnetic 3D bioprinting
Amount: $999,999.00PROJECT SUMMARYThe goal of this proposal is to develop assays for cardiotoxicity and hepatotoxicity using magneticD bioprintingBoth cardiotoxicity and hepatotoxicity are critical areas for safety test ...
SBIRPhase II2017Department of Health and Human Services National Institutes of Health -
Novel 3D high-content/throughput assay with mobile device-based data acquisition
Amount: $150,000.00DESCRIPTION (provided by applicant): Currently available models for toxicity screening are not always accurate predictors of toxicity in humans. Animal models are commonly used, but they are costly, t ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
A novel 3D cell culture human uterine contractility assay for high-throughput scr
Amount: $190,468.00DESCRIPTION (provided by applicant): Several disorders in reproductive medicine are results of changes in smooth muscle contractile activity. Increased myometrial contraction can lead to preterm labor ...
STTRPhase I2014Department of Health and Human Services National Institutes of Health -
SBIR Phase II: In Vitro 3D Tissue Model for Toxicity Screening and Drug Discovery
Amount: $500,000.00This Small Business Innovation Research (SBIR) Phase II project will use in vitro three-dimensional (3D) cell culturing enabled by the magnetic levitation method (MLM) as an improved tool for toxicity ...
SBIRPhase II2011National Science Foundation -
SBIR Phase I:In Vitro 3D Lung Tissue Model for Drug Discovery and Toxicity Screening
Amount: $199,489.00This Small Business Innovation Research (SBIR) Phase I project is the development of a lung tissue model based on a new cell culturing platform utilizing nanoparticle-based reagents and magnetic field ...
SBIRPhase I2010National Science Foundation